Lam Research introduced Dextro, a collaborative robot arm to optimize maintenance tasks on semiconductor wafer fabrication equipment, deployed in multiple advanced wafer fabs worldwide.

Source: https://www.therobotreport.com/feed/

Capstan Medical Inc. raised $110 million in an oversubscribed Series C round, bringing its total funding to over $150 million. The company plans to use the funds for its next phase of business, including a surgical robot and catheter-delivered implants for heart valve replacement.

Source: https://www.therobotreport.com/feed/

Microbot Medical submitted a 510(k) premarket notification to the FDA for its LIBERTY surgical robot, expecting FDA clearance in Q2 2025.

Source: https://www.therobotreport.com/feed/

Simbe Robotics is expanding its inventory management robot, Tally, into farm supply retail. Country Supplier LLC, a farm supply company serving several western states, will deploy Tally robots in its C-A-L Ranch and Coastal Farm & Ranch stores after a successful trial.

Source: https://www.therobotreport.com/feed/

ANYbotics, a company that specializes in legged robots for industrial facility inspections, has raised $60 million to accelerate its global and U.S. expansion.

Source: https://www.therobotreport.com/feed/

Endiatx CEO Torrey Smith discusses the PillBot, an ingestible robot undergoing clinical trials to navigate the stomach under a doctor's remote control.

Source: https://www.therobotreport.com/feed/

Universal Robots is expanding its presence in China by opening a production facility in Nantong and introducing two new cobots, the UR7e and UR12e, exclusively for the Chinese market.

Source: https://www.therobotreport.com/feed/

Ambi Robotics, a California-based automation provider, has enhanced its robots to handle increased demand during the busy holiday season. By analyzing past data, the company has enabled its robots to increase utilization and shift from a reactive to a proactive approach for peak season, which is shorter than usual this year due to a late Thanksgiving.

Source: https://www.therobotreport.com/feed/

General Motors will stop funding Cruise's robotaxi development due to long development times, high costs, and a competitive market. The company will combine Cruise and GM technical teams to advance autonomous driving.

Source: https://www.therobotreport.com/feed/

General Motors (GM) has stopped funding Cruise LLC's robotaxi deployment due to lengthy development times, high costs, and increased competition. Despite investing over $10 billion in Cruise since 2016, GM will now integrate Cruise's technical team with GM's to focus on autonomous and assisted driving technologies.

Source: https://www.therobotreport.com/feed/